Core Laboratories Inc

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the following business segments: Reservoir Description and Production Enhancement. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Core Labs reports strong Q4 performance, eyes growth opportunities

Core Laboratories Inc delivered a solid performance in Q4 2022, focusing on financial strength, operational efficiency, and future growth prospects. Despite facing challenges from external factors, the company remains optimistic about opportunities in the energy sector and its ability to create value for shareholders.

Core Laboratories Inc reports robust Q1 earnings, eyes EOR opportunities

Core Laboratories Inc delivered strong financial results, highlighted operational efficiencies, and outlined growth strategies amidst industry challenges. The company's focus on innovation, debt reduction, and cost savings bodes well for future performance and shareholder value.

Core Labs reports solid Q2 performance, eyes international growth

Core Laboratories Inc showcased strong financial performance in Q2 2023, with a focus on operational efficiency and technological advancement.
The company's commitment to maximizing free cash flow, returns on invested capital, and shareholder value underscores its financial discipline and strategic priorities.
Despite challenges in the US land sector, Core Labs remains optimistic about international growth opportunities and technological advancements driving future success.

Core Laboratories Inc reports strong Q3 performance amidst market challenges

Core Laboratories Inc delivered a strong Q3 performance with improvements in key financial metrics. While facing challenges in certain segments, the company's strategic focus on innovation and efficiency positions it well for future opportunities. Core Labs remains optimistic about its outlook and is committed to driving growth and value for shareholders.

Core Laboratories reports steady Q4 performance amidst operational challenges

Core Laboratories navigated challenges in Q4 with a focus on debt reduction, innovation, and operational excellence, showcasing resilience and adaptability.
While facing headwinds in certain segments, Core Labs remains committed to long-term sustainability, shareholder value, and technological advancement.
Strategic initiatives and operational highlights underscore Core's leadership in the industry, setting the stage for future growth and market expansion.

Core Labs maintains steady performance amidst geopolitical challenges and debt reduction

Core Laboratories Inc delivered a resilient performance in Q1 2024, focusing on operational efficiency and debt reduction amidst external challenges.
The company's strategic strengths lie in international growth prospects, technology investments, and commitment to financial stability.
Challenges from geopolitical conflicts and operational disruptions highlight the need for adaptability and diversification in Core Labs' business approach.
Opportunities abound in capitalizing on international growth, technology advancements, and maximizing return on invested capital for sustainable growth.

Core Laboratories reports revenue growth and debt reduction in Q3

Core Laboratories Inc delivered a solid financial performance in Q3 2024, with revenue growth, improved margins, and reduced debt levels.
While facing challenges in a competitive market and capital expenditure constraints, the company remains focused on sustaining profitability and operational efficiency.
Opportunities lie in leveraging segment revenue growth, debt reduction strategies, and exploring new avenues for expansion and partnerships.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Core Laboratories Inc. provides proprietary and patented reservoir description and production enhancement services. The company was founded on May 1, 2023 and is headquartered in Houston, TX.

Core Laboratories (CLB) delivered earnings and revenue surprises of 15.38% and -1.61%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Q1 Earnings Top Estimates

Shares of Core Laboratories (NYSE:CLB) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 51.61% over the past year to $0.15, which beat the estimate of $0.13.

Recap: Core Laboratories Q1 Earnings

AMSTERDAM, April 21, 2021 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported continuing operations resulted in first quarter 2021 revenue of $108,400,000.

Core Lab Reports First Quarter 2021 Results From Continuing Operations:

CLB grew quarterly revenue 8% Q/Q. North America land drilling is showing signs of life. Cost containment efforts and added scale could amplify EBITDA growth.

Core Laboratories: Growth Should Continue After The Economy Reopens

Centennial Resource Development

SM Energy

The energy sector got a boost from an updated look at oil demand, with some names rising sharply.

Why Shares of Core Labs, SM Energy, and Centennial Resource Development Were Big Movers Today

Why Core Laboratories' Shares Popped 7.1% Today

The energy services company has been caught in the ups and downs of the broader energy sector. Here's why that's par for the course.

Why Core Laboratories Stock Fell 6% Today

AMSTERDAM, March 22, 2021 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2021 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m.

Core Laboratories' First Quarter 2021 Webcast At 7:30 A.M. CDT / 2:30 P.M.

Why Core Laboratories Shares Plunged 11.9% Today

Schlumberger

In this article, I review how my recent call of going long oilfield service stocks has fared. It's encouraging to see oilfield service stocks began to participate in the bullish upturn of the benchmark oil price.

Schlumberger And Core Laboratories: Oilfield Service Firms In An Oil Upswing

Core Laboratories N.V. (CLB) CEO Larry Bruno on Q4 2020 Results - Earnings Call Transcript

Shares took a roller coaster ride today, as the big news was earnings.

Why Core Laboratories Stock Rose 5% and Fell 5% on the Same Day

In the December quarter, Core Labs (CLB) generates $57.9 million in operating cash and its capital expenditure totals $11.9 million, leading to a $46-million free cash flow (FCF) recognition.

Core Labs' (CLB) Q4 Earnings and Revenues Beat Estimates

Core Laboratories (CLB) delivered earnings and revenue surprises of 5.88% and 3.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Core Laboratories (CLB) Q4 Earnings and Revenues Top Estimates

It's time to have a bird's-eye view of the upstream oil industry using information gleaned from a variety of industry sources.

Schlumberger And Core Laboratories: Industry Condition Is Ripening For Going Long

On Wednesday, January 27, Core Laboratories (NYSE:CLB) will release its latest earnings report. Here is Benzinga's outlook for the company.

A Preview Of Core Laboratories's Earnings

Core Laboratories' (CLB) cost-saving measures are expected to have driven fourth-quarter earnings and cash flows higher.

What's in Store for Core Laboratories (CLB) in Q4 Earnings?

Baker Hughes Co

Cost-cutting measures and demand recovery for oilfield equipment & services have likely aided companies belonging to the oilfield service space in Q4. SLB, BKR & CLB are yet to report earnings.

What's in Store for Oilfield Service in Q4 Earnings?

Enterprise Products Partners

Golar LNG

Occidental Petroleum

The energy markets got a shock, and it rippled across the entire industry landscape. There are lessons here.

Why Shares of Golar LNG, Enterprise Products Partners, SM Energy, Occidental, and Core Labs Rallied Today

EOG Resources

Diamondback Energy

Marathon Oil

Why These 5 Oil Stocks Were Soaring Today

AMSTERDAM, Dec. 28, 2020 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its fourth quarter 2020 conference call over the Internet at 7:30 a.m. CST / 2:30 p.m. CET on January 28, 2021. Larry Bruno, Chairman, CEO and President, Chris Hill,...

Core Laboratories' Fourth Quarter 2020 Webcast At 7:30 A.M. CST / 2:30 P.M.

Madison Square Garden Entertainment

John Rogers (Trades, Portfolio), leader of Ariel Investments, disclosed earlier this week his firm upped its stakes in Core Laboratories NV (NYSE:CLB) and Madison Square Garden Entertainment Corp. (NYSE:MSGE).

John Rogers' Firm Ups Stakes in 2 Companies

Kosmos Energy

Energy stocks from across the spectrum rose along with the key products the sector produces. Here's what you need to know.

Why Core Laboratories, SM Energy, and Kosmos Energy Rallied as Much as 12% Today

Core Laboratories Nv shows rising price performance, earning an upgrade to its IBD Relative Strength Rating The post Core Laboratories Nv Sees IBD RS Rating Rise To 78 appeared first on Investor's Business Daily.

Core Laboratories Nv Sees IBD RS Rating Rise To 78

Helix Energy Solutions Group

QEP Resources

Oil prices were lower today, but investors in the energy patch were watching OPEC and not liking what they saw.

News for Core Laboratories Inc Stock (CLB)